Advertisement

Quality Control Methods of 99mTc Pharmaceuticals

  • C Decristoforo
  • I Zolle
  • F. Rakiás
  • J Imre
  • Gy. Jánoki
  • S. R. Hesslewood
Chapter

Keywords

Radiochemical Purity Solvent Front European Pharmacopeia Quality Control Method 99mTc Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References

  1. Bish RE, Silverstein D, Bede JI (1980) Radiopharmaceutical-radiochromatography quality assurance with a radioisotope calibrator. J Radioanal Chem 57:565–573CrossRefGoogle Scholar
  2. Carpenter AP (1986) Radioanalytical techniques: ITLC, TLC, mini columns and electrophoresis. In: Wieland DM, Tobes MC, Mangner TJ (eds) Analytical and chromatographic techniques in radiopharmaceutical chemistry. Springer, Berlin Heidelberg New YorkGoogle Scholar
  3. Council of Europe (1982) Sodium pertechnetate [99mTc] injection (fission), Monograph (124). European pharmacopeia. StrasbourgGoogle Scholar
  4. Decristoforo C, Zaknun J, Kohler B, Oberladstaetter M, Riccabona G (1997) The use of electronic autoradiography in radiopharmacy. Nucl Med Biol 24:361–365PubMedCrossRefGoogle Scholar
  5. Dickey EE (1953) Separation of radium D, E and F by paper chromatography. J Chem Ed 30:525CrossRefGoogle Scholar
  6. Fairbrother JE (1984) Advances in TLC in two parts: Part 1 — Techniques. Pharm J 10 March:293–297; Part 2 — Applications. Pharm J 7 July:23–28Google Scholar
  7. Filthuth H (1986) Detection of radiochromatograms and electropherograms with position-sensitive wire chambers. In: Wieland DM, Tobes MC, Mangner TJ (eds) Analytical and chromatographic techniques in radiopharmaceutical chemistry. Springer, Berlin Heidelberg New YorkGoogle Scholar
  8. Frier M, Hesslewood S (1980) Quality assurance of radiopharmaceuticals — a guide to hospital practice. Nucl Med Comm, Special Issue 3Google Scholar
  9. Hammermaier A, Reich E, Bögl W (1986) Qualitätskontrolle von in-vivo Radiopharmaka, ein Handbuch für das nuklearmedizinische Labor zur Analytik radiochemischer Verunreinigungen [in German]. ISH-Heft 94Google Scholar
  10. Höye, A (1967) Determination of radiochemical purity of some radiochemicals and pharmaceuticals by paper chromatography, thin-layer chromatography and high voltage electrophoresis. J Chromatograpy 28:379CrossRefGoogle Scholar
  11. Izmailov, N.A. Shraiber MS (1938) The application of analysis by drop chromatography to pharmacy. Farmezia 3:1Google Scholar
  12. Janshold, AL, Krohn KA, Vera DR, Hines HH (1980) Design and validation of a radiochromatogram scanner with analog and digital output. J Nucl Med Tech 8:222Google Scholar
  13. Levit N (1980) Radiopharmacy laboratory manual for nuclear medicine technologists. University of New Mexico College of Pharmacy Albuquerque, pp 69–80Google Scholar
  14. Mallol J (1990) Analytical artifacts in quality control of Tc-99m radiopharmaceuticals. Nucl Med Biol 17:609–611Google Scholar
  15. Mangner TJ (1986) Potential artifacts in the chromatography of radiopharmaceuticals. In: Wieland DM, Tobes MC, Mangner TJ (eds) Analytical and chromatographic techniques in radiopharmaceutical chemistry. Springer, Berlin Heidelberg New YorkGoogle Scholar
  16. Miller JM (2004) Chromatography: concepts and contrasts, 2nd edn. Wiley, New YorkGoogle Scholar
  17. Robbins PJ (1983) Chromatography of technetium-99m radiopharmaceuticals — a practical guide. The Society of Nuclear Medicine, New YorkGoogle Scholar
  18. Stahl E (1956) Dünnschicht-Chromatgraphie [in German]. Pharmazie 11:633PubMedGoogle Scholar
  19. Theobald AE (1994) Quality control of radiopharmaceuticals. In: Sampson CB (ed) Textbook of radiopharmacy: theory and practice, 2nd enlarged edn. Gordon and Breach, PhiladelphiaGoogle Scholar
  20. Westera G, Gadze A, Horst W (1985) A convenient method for the preparation of 99m Tc(V) dimer-captosuccinic acid (99mTc(V)-DMSA). Int J Appl Radiat Isot 36:349–355CrossRefGoogle Scholar
  21. Zimmer AM, Pavel DG (1977) Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals. J Nucl Med 18:1230–1233PubMedGoogle Scholar

References

  1. Brandau W, Bubeck B, Schober O, Weber E, Taylor DM (1990) 99mTc-MAG3: chemistry and biokinetics of by-products. In: Blaufox MD, Hollenberg NK, Raynaud C (eds) Radionuclides in nephrourology. Karger, Basel pp 11–16Google Scholar
  2. Cagnolini A, Whitener D, Jurisson S (1998) Comparison of the kit performance of three 99mTc myocardial perfusion agents. Nucl Med Biol 25:435–439PubMedCrossRefGoogle Scholar
  3. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516–1522PubMedGoogle Scholar
  4. Council of Europe (2005) European pharmacopeia. Council of Europe, Maisonneuve, Sainte-RuffineGoogle Scholar
  5. Coveney JR, Robbins MS (1987) Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats. J Nucl Med 28:1881–1887PubMedGoogle Scholar
  6. De Groot GJ, Das HA, deLigny CL (1986a) A system for high performance liquid chromatography of Tc-99m complexes with on-line radiometric detection and data processing. Int J Appl Radiat Isot 37:349–355Google Scholar
  7. De Groot GJ, Das HA, deLigny CL (1986b) Separation of Tc-99m(Sn)HEDP complexes by HPLC and GPC. Int J Appl Radiat Isot 37:23–27CrossRefGoogle Scholar
  8. Fritzberg AR, Lewis D (1980) HPLC analysis of Tc-99m iminodiacetate hepatobiliary agents and a question of multiple peaks: concise communication. J Nucl Med 21:1180–1184PubMedGoogle Scholar
  9. Graham D, Millar AM (1999) Artefacts in the thin-layer chromatographic analysis of 99Tcm-tetrofosmin injections. Nucl Med Commun 20:439–444PubMedCrossRefGoogle Scholar
  10. Hnatowich DJ (1986) HPLC of radiolabelled antibodies. In: Wieland DM, Tobes MC, Manger TJ (eds) Analytical and chromatographic techniques in radiopharmaceutical chemistry. Springer, Berlin Heidelberg New YorkGoogle Scholar
  11. Hoch DJ, Pinkerton TC (1986) Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate. Int J Rad Appl Instrum 37:593–598CrossRefGoogle Scholar
  12. Huigen YM, Gelsema WJ, de Ligny C (1988) Effect of the composition of the eluent in the chromatography of 99mTc-diphosphonate complexes. Int J Rad Appl Instrum 39:381–384CrossRefGoogle Scholar
  13. Hung JC, Corlija M, Volkert WA, Holmes RA (1988) Kinetic analysis of technetium-99m D,L-HM-PAO decomposition in aqueous media. J Nucl Med 29:1568–1576PubMedGoogle Scholar
  14. Hung JC, Wilson ME, Brown ML, Gibbons RJ (1991) Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi). J Nucl Med 32:2162–2168PubMedGoogle Scholar
  15. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill HK, McPartlin M (1993) Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 34:222–227PubMedGoogle Scholar
  16. Millar AM (1989) Quality assurance of radiopharmaceuticals. In: Theobald AE (1989) Radiophar-maceuticals and radiotracers in pharmacy. Ellis Horwood, Chichester, UKGoogle Scholar
  17. Millar AM, Wilkinson AG, McAteer E, Best JJK (1990) 99mTc-MAG3: in vitro stability and in vivo behaviour at different times after preparation. Nucl Med Commun 11:405–412PubMedGoogle Scholar
  18. Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Picket RD, Holmes RA, Volkert WA, Foster AM, Weisner PS, Marriot JA, Chaplin SB (1987) Tchnetium-99m D,L-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood flow. J Nucl Med 28:191–202PubMedGoogle Scholar
  19. Nieuwland RJ, Das HA, de Ligny CL (1989) Improvement of the reproducibility of ion-pair HPLC of 99mTc(Sn)EHDP complexes and the influence of the Sn(II) concentration on the composition of the reaction mixture. Int J Rad Appl Instrum 40:153–157CrossRefGoogle Scholar
  20. Nunn AD (1983) Structure-distribution relationships of radiopharmaceuticals. Correlation between the reversed-phase capacity factors for Tc-99m phenylcarbamoyl-methyliminodiacetic acids and their renal elimination. J Chromatogr 255:91–100PubMedCrossRefGoogle Scholar
  21. Nunn AD, Fritzberg AR (1986) Components for the design of a radio-HPLC system. In: Wieland DM, Tobes MC, Manger TJ (eds) Analytical and chromatographic techniques in radiopharmaceutical chemistry. Springer, Berlin Heidelberg New YorkGoogle Scholar
  22. Nunn AD, Loberg MD, Conley RA (1983) A structure-distribution-relationship approach leading to the development of Tc-99m-mebrofenin: an improved cholescintigraphic agent. J Nucl Med 24:423–430PubMedGoogle Scholar
  23. Shattuck LA, Eshima D, Taylor AT, Anderson TL, Graham DL, Latino FA, Payne SE (1994) Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity. J Nucl Med 35:349–355PubMedGoogle Scholar
  24. Tanabe S, Zodda JP, Deutsch E, Heineman WR (1983) Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues. Int J Appl Radiat Isot 34:1577–1584PubMedCrossRefGoogle Scholar
  25. Vallabhajosula S, Goldsmith SJ, Pollina R, Lipszyc H (1982) Radiochemical analysis of Tc-99m human serum albumin with high pressure liquid chromatography. J Nucl Med 23:326–329PubMedGoogle Scholar
  26. Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Lipszyc H, Lee H, Bastidas D, Dean RT (1996) Preclinical evaluation of technetium-99m-labelled somatostatin receptor-binding pep-tides. JNM 37:1016–1022PubMedGoogle Scholar
  27. Weisner PS, Bower GR, Dollimore LA, Forster AM, Higley B, Storey AE (1993) A method for stabilising technetium-99m exametazime prepared from a commercial kit. Eur J Nucl Med 20:661–666PubMedCrossRefGoogle Scholar
  28. Zinn KR, Buchsbaum DJ, Chaudhuri TR, Mountz JM, Grizzle WE, Rogers BE (2000) Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med 41:887–895PubMedGoogle Scholar

References

  1. Belkas EP, Archimandritis S (1979) Quality control of colloid and paniculate 99mTc-labelled radio-pharmaceuticals. Eur J Nucl Med 4:375PubMedCrossRefGoogle Scholar
  2. Pauwels EKJ, Feitsma RIJ (1977) Radiochemical quality control of 99mTc-labelled radiopharmaceuticals. Eur J Nucl Med 2:97PubMedCrossRefGoogle Scholar
  3. Wieme RJ (1965) Agar gel electrophoresis. Elsevier, AmsterdamGoogle Scholar

References

  1. Booster P (1982) Statistische Methoden im Laboratorium [in German]. Elsevier, AmsterdamGoogle Scholar
  2. Eckelman W, Meinken G, Richards P (1971) Chemical state of Tc-99m in biomedical products. J Nucl Med 12:596–600PubMedGoogle Scholar
  3. Rakiás F, Zolle I (1997) Stannous ion determination: importance and relevance for radiopharmaceutical kits. In: Bergmann H, Kroiss A, Sinzinger H (eds) Radioactive isotope in clinical medicine and research, vol. 22. Birkhauser, Basel, pp 401–409Google Scholar
  4. Rakias F, Kelemen-Küttel I, Tömpe P, Nemeth P, PaaI TL (1988) Correlation between the Sn(II)-content of phosphonate, phytate, and gluconate kits and the quality of the obtained images. In: Höfer R, Bergmann H (eds) Radioactive isotope in clinic und research, vol. 18. Schattauer, Stuttgart, pp 417–419Google Scholar

References

  1. Brown S, Baker MH (1986) The sterility testing of dispensed radiopharmaceuticals. Nucl Med Commun 7:327–336PubMedCrossRefGoogle Scholar
  2. Stathis VJ, Miller CM, Doerr GF, Coffey JL, Hladik WB (1983) Effect of technetium Tc-99m pertechnetate on bacterial survival in solution. Am J Hosp Pharm 40:634–637PubMedGoogle Scholar
  3. Wind K (1985) Sterility testing. In: Cox PH (ed) Radiopharmacy and radiopharmacology, yearbook 1. Gordon and Breach, London, pp 35–46Google Scholar

Copyright information

© Springer Berlin Heidelberg 2007

Authors and Affiliations

  • C Decristoforo
  • I Zolle
  • F. Rakiás
    • 1
  • J Imre
    • 2
  • Gy. Jánoki
    • 3
  • S. R. Hesslewood
    • 4
  1. 1.Drug Quality DepartmentNational Institute of PharmacyBudapestHungary
  2. 2.Radiochemistry SectionNational Institute of PharmacyBudapestHungary
  3. 3.Department of Applied RadioisotopesFrederic Joliot-Curie National Research Institute of Radiobiology and RadiohygieneBudapestHungary
  4. 4.Department of Physics and Nuclear MedicineCity Hospital NHS TrustBirminghamUK

Personalised recommendations